VT
ViCardia Therapeutics, Inc.
SEC filingBiotechnology · San Francisco, CA
Amount raised$700Ksold at filing
Total offering$700K
Investors in the raise1count reported to the SEC
FiledMay 21, 2026first sale May 19, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Michael KokeshExecutive Officer
Executive officers, directors and promoters as listed on the Form D.